Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Carbonyl reductase 3 pseudogene (ENSG00000257738; LOC100419293) is classified as a pseudogene—an inactive genetic sequence related to the functional carbonyl reductase 3 (CBR3) gene, which encodes an NADPH-dependent oxidoreductase enzyme. Unlike CBR3, the pseudogene does not produce a functional protein and is not a target for drugs or therapies. Pseudogenes such as this one sometimes play regulatory roles in gene expression by interacting with RNA or DNA, but there is no evidence of such function for this specific pseudogene. Therapeutic interest, disease associations, drug interactions, and biomarkers are all connected solely to the functional CBR3 protein, not its pseudogene. The presence of this entry may reflect database inclusion of genetic elements that are present in the genome but not actionable in pharmacology or medicine. For structured data purposes, this entry should be flagged as not a conventional drug target (is_target = false), and potential confusion with the active CBR3 gene should be explicitly noted (is_incorrect = true).
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Carbonyl reductase 3 pseudogene.